About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Tlsm1AKR/JMs
AKR/JMs
MGI:2156830
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
 		Tlsm1AKR/JMs/Tlsm1AKR/JMs involves: AKR/JMs * SL/Kh MGI:2175596
ht2
 		Tlsm1AKR/JMs/Tlsm1SL/Kh involves: AKR/JMs * SL/Kh MGI:2175597


Genotype
MGI:2175596
hm1
Allelic
Composition		 Tlsm1AKR/JMs/Tlsm1AKR/JMs
Genetic
Background		 involves: AKR/JMs * SL/Kh
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tlsm1AKR/JMs mutation (1 available); any Tlsm1 mutation (2 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
neoplasm
increased T cell derived lymphoma incidence ( J:21741 , J:33016 , J:41197 )
• susceptibility to T-lymphomas (J:21741)
• susceptibility to T-lymphomas (J:33016)
• susceptibility to T-lymphomas (J:41197)

endocrine/exocrine glands
increased T cell derived lymphoma incidence ( J:21741 , J:33016 , J:41197 )
• susceptibility to T-lymphomas (J:21741)
• susceptibility to T-lymphomas (J:33016)
• susceptibility to T-lymphomas (J:41197)

immune system
increased T cell derived lymphoma incidence ( J:21741 , J:33016 , J:41197 )
• susceptibility to T-lymphomas (J:21741)
• susceptibility to T-lymphomas (J:33016)
• susceptibility to T-lymphomas (J:41197)

hematopoietic system
increased T cell derived lymphoma incidence ( J:21741 , J:33016 , J:41197 )
• susceptibility to T-lymphomas (J:21741)
• susceptibility to T-lymphomas (J:33016)
• susceptibility to T-lymphomas (J:41197)




Genotype
MGI:2175597
ht2
Allelic
Composition		 Tlsm1AKR/JMs/Tlsm1SL/Kh
Genetic
Background		 involves: AKR/JMs * SL/Kh
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tlsm1AKR/JMs mutation (1 available); any Tlsm1 mutation (2 available)
Tlsm1SL/Kh mutation (1 available); any Tlsm1 mutation (2 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
neoplasm
increased T cell derived lymphoma incidence ( J:21741 , J:33016 , J:41197 )
• susceptibility to T-lymphomas (J:21741)
• susceptibility to T-lymphomas (J:33016)
• susceptibility to T-lymphomas (J:41197)

endocrine/exocrine glands
increased T cell derived lymphoma incidence ( J:21741 , J:33016 , J:41197 )
• susceptibility to T-lymphomas (J:21741)
• susceptibility to T-lymphomas (J:33016)
• susceptibility to T-lymphomas (J:41197)

immune system
increased T cell derived lymphoma incidence ( J:21741 , J:33016 , J:41197 )
• susceptibility to T-lymphomas (J:21741)
• susceptibility to T-lymphomas (J:33016)
• susceptibility to T-lymphomas (J:41197)

hematopoietic system
increased T cell derived lymphoma incidence ( J:21741 , J:33016 , J:41197 )
• susceptibility to T-lymphomas (J:21741)
• susceptibility to T-lymphomas (J:33016)
• susceptibility to T-lymphomas (J:41197)




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory